Begin main content

Search

We found 5943 result(s)

The pCODR Expert Review Committee (pERC)

Published on: October 18, 2018
Result type: General Content

The role of the pan-Canadian Oncology Drug Review (pCODR) Expert Review Committee (pERC) is to assess the clinical evidence and cost-effectiveness of cancer drugs in order to make recommendations to the provinces and territories to help guide their drug funding decisions. A submission for the assessment of a cancer drug may be made by a pharmace...

Nusinersen (Spinraza)

Last Updated: October 16, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: Nusinersen
Indications: Spinal Muscular Atrophy

  • Brand Name: Spinraza
  • Manufacturer: Biogen Canada Inc.
  • Project Number: SR0576-000
  • Project Status: Active
  • Submission Type: Resubmission

Tags

Genetics, Nervous System, Pediatrics, Genetics, Musculoskeletal, Nervous system, Pediatrics

ertugliflozin and metformin (Segluromet)

Last Updated: October 16, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: ertugliflozin and metformin hydrochloride
Indications: Diabetes mellitus, Type 2

  • Brand Name: Segluromet
  • Manufacturer: Merck Canada Inc.
  • Project Number: SR0566-000
  • Project Status: Active
  • Submission Type: NewCombination

Tags

Diabetes Mellitus, Diabetes, segluromet; ertugliflozin; metformin; Diabetes; Diabetic

ertugliflozin (Steglatro)

Last Updated: October 16, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: ertugliflozin
Indications: Diabetes mellitus, Type 2

  • Brand Name: Steglatro
  • Manufacturer: Merck Canada Inc.
  • Project Number: SR0565-000
  • Project Status: Active
  • Submission Type: New

Tags

Diabetes Mellitus, Diabetes, steglatro; ertugliflozin; Diabetes; Diabetic

insulin glargine (Semglee)

Last Updated: October 16, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: insulin glargine
Indications: Diabetes mellitus, Type 1 & 2

  • Brand Name: Semglee
  • Manufacturer: BGP PHARMA ULC
  • Project Number: SE0589-000
  • Project Status: Pending
  • Submission Type: New